Neuromyelitis Optica Clinical Trials in Boston, Massachusetts
5 recruitingBoston, Massachusetts
Showing 1–5 of 5 trials
Recruiting
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
PregnancyParoxysmal Nocturnal Hemoglobinuria, PNHUltomiris-exposed Pregnant/ Postpartum+3 more
Alexion Pharmaceuticals, Inc.75 enrolled7 locationsNCT06312644
Recruiting
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Neuromyelitis Optica Spectrum DisorderNMOSDAQP4+ NMOSD
Alexion Pharmaceuticals, Inc.122 enrolled33 locationsNCT05966467
Recruiting
Phase 2
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Amgen15 enrolled19 locationsNCT05549258
Recruiting
Phase 2Phase 3
Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD
Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc.12 enrolled21 locationsNCT05346354
Recruiting
Not Applicable
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
Neuromyelitis Optica
Ad scientiam103 enrolled22 locationsNCT05566769